CANSEQ Trademark

Trademark Overview


On Monday, September 10, 2012, a trademark application was filed for CANSEQ with the United States Patent and Trademark Office. The USPTO has given the CANSEQ trademark a serial number of 85724752. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 30, 2022. This trademark is owned by Dana-Farber Cancer Institute, Inc.. The CANSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; medical services in the fields of diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical services, namely, administering cancer treatments and therapies based on or that take into account the genetic characteristics or composition of patients or patients' diseases; providing medical information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals

Scientific research services; scientific and research service development, namely, development of technologies and algorithms for performing genomic analyses of patients' cancer cells and normal cells for the purposes of guiding their medical management and treatment; and scientific services, namely, scientific laboratory services in the fields of genetics, genome sequencing and cancer medicine, diseases, medical conditions and disorders, biology, and pharmaceuticals; informational services, namely, providing medical research information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical and scientific research services, namely, identifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapies, and the reasons for such likelihood, inherited risk or resistance, and that are useful in hel...
canseq

General Information


Serial Number85724752
Word MarkCANSEQ
Filing DateMonday, September 10, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 30, 2022
Registration Number4918431
Registration DateTuesday, March 15, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2013

Trademark Statements


Goods and ServicesMedical services; medical services in the fields of diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical services, namely, administering cancer treatments and therapies based on or that take into account the genetic characteristics or composition of patients or patients' diseases; providing medical information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals
Goods and ServicesScientific research services; scientific and research service development, namely, development of technologies and algorithms for performing genomic analyses of patients' cancer cells and normal cells for the purposes of guiding their medical management and treatment; and scientific services, namely, scientific laboratory services in the fields of genetics, genome sequencing and cancer medicine, diseases, medical conditions and disorders, biology, and pharmaceuticals; informational services, namely, providing medical research information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical and scientific research services, namely, identifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapies, and the reasons for such likelihood, inherited risk or resistance, and that are useful in helping to predict the prognosis, clinical course, and likelihood of recurrence of patients' cancers, illnesses or malignancies and the effectiveness of treatments and therapies therefor

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 30, 2022
Primary Code042
First Use Anywhere DateThursday, February 28, 2013
First Use In Commerce DateThursday, February 28, 2013

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 30, 2022
Primary Code044
First Use Anywhere DateThursday, February 28, 2013
First Use In Commerce DateThursday, February 28, 2013

Trademark Owner History


Party NameDana-Farber Cancer Institute, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 022155450

Party NameDana-Farber Cancer Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 022155450

Party NameDana-Farber Cancer Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 022155450

Trademark Events


Event DateEvent Description
Friday, September 30, 2022CANCELLED SEC. 8 (6-YR)
Monday, March 15, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 15, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 8, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 21, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 17, 2015USE AMENDMENT FILED
Thursday, December 17, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, July 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 14, 2015SOU EXTENSION 4 GRANTED
Tuesday, July 14, 2015SOU EXTENSION 4 FILED
Tuesday, July 14, 2015TEAS EXTENSION RECEIVED
Friday, March 13, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 13, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 23, 2014SOU EXTENSION 3 GRANTED
Tuesday, December 16, 2014SOU EXTENSION 3 FILED
Tuesday, December 16, 2014TEAS EXTENSION RECEIVED
Thursday, August 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, August 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 19, 2014SOU EXTENSION 2 GRANTED
Tuesday, July 22, 2014SOU EXTENSION 2 FILED
Friday, August 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 22, 2014TEAS EXTENSION RECEIVED
Saturday, January 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, January 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2014SOU EXTENSION 1 GRANTED
Wednesday, January 22, 2014SOU EXTENSION 1 FILED
Wednesday, January 22, 2014TEAS EXTENSION RECEIVED
Tuesday, July 23, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 19, 2013ASSIGNED TO LIE
Thursday, March 28, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 3, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2012NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2012NON-FINAL ACTION WRITTEN
Friday, September 28, 2012ASSIGNED TO EXAMINER
Friday, September 14, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 13, 2012NEW APPLICATION ENTERED IN TRAM